Metraipolis › archive › dc_7ff3a43d9edf

Redefining the Limits of Nanodevices-Based Drug Delivery Systems: Extracellular Vesicles — Europe PMC PMID:41471130

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41471130
DOI
10.3390/pharmaceutics17121617
License (as archived)
solo-consultazione
Archived
2026-11-07T15:03:27.403Z
SHA-256 of the archived text
553b9416caec5d4e032ef8456d1facab81dfee5080f1615dca57829ec17b34d7
Stable URL of this page
https://metraipolis.com/documento/dc_7ff3a43d9edf

How to cite

Redefining the Limits of Nanodevices-Based Drug Delivery Systems: Extracellular Vesicles — Europe PMC PMID:41471130 — Europe PMC (en), https://europepmc.org/article/MED/41471130 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7ff3a43d9edf (Metraipolis archive dc_7ff3a43d9edf, sha256 553b9416caec5d4e032ef8456d1facab81dfee5080f1615dca57829ec17b34d7)
BibTeX
@misc{dc7ff3a43d9edf,
  title = {Redefining the Limits of Nanodevices-Based Drug Delivery Systems: Extracellular Vesicles — Europe PMC PMID:41471130},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41471130},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7ff3a43d9edf; sha256 553b9416caec5d4e032ef8456d1facab81dfee5080f1615dca57829ec17b34d7},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41471130. Agents can read the archived copy with the MCP tool read_document.